2009-010261-23
Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation
Vertex Pharmaceuticals Incorporated·EU Clinical Trials Register
Study focus
- Disease/Condition
- Cystic Fibrosis
Sponsor & location
- Primary sponsor
- Vertex Pharmaceuticals Incorporated
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- History of any illness or condition that, in the opinion of the investigator, might confound the results of the study or pose an additional risk in administering study drug to the subject
ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2009-010261-23
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2009-010261-23 through Pure Global AI's free database. This phase not specified trial is sponsored by Vertex Pharmaceuticals Incorporated and is currently status unknown. The study focuses on Cystic Fibrosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.